Hemopoietic progenitor cell identification in fetal and adult blood

Hemopoietic progenitor cells give rise to all cellular elements of the blood and are of importance as a potential source of cells used for correction of various pathological conditions. The main objective of this study was to identify and quantitative hemopoietic progenitor cell in antenatal fetal blood, in cord blood at the time of delivery and in adult blood, using monoclonal antibodies to surface markers and flow cytometry. CD34+ cells, most of them probably representing progenitor cells, were detected in prenatal fetal blood as early as the 17th week of gestation. The proportion of these cells showed a tendency to decrease as the pregnancy progressed. Within the population of CD34+ cells, a relatively low proportion (less than 1%) were negative for the surface marker CD33 or HLA-Dr, indicating a population of primitive stem cells, i.e., progenitor cells no committed to a specific lineage. On the contrary, another group coexpressed CD33 or HLA-Dr, being more mature progenitor cells already committed to differentiate along a specific lineage. The percentage of CD34+ obtained in blood of adult patients after mobilization with chemotherapeutic agents and growth factors showed an average value of 2.7± 3.1%. The percentage of CD34+ in the apheresis products of various patients varied from 0.58 to 1.48. In some cases the cells were reinfused in the patient with good results. Our findings are in agreement with previous studies suggesting that CD34+ stem cells is a heterogeneous population, with each subset having variable degree o commitment to differentiate toward a specific cell lineage.

Saved in:
Bibliographic Details
Main Authors: Müller,Aixa, Soyano,Andrés, Guevara,Freddy, Martínez,Bahilda, Soyano,Alberto, Ponte,Benita
Format: Digital revista
Language:English
Published: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular 2008
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800006
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1516-84842008000800006
record_format ojs
spelling oai:scielo:S1516-848420080008000062008-12-09Hemopoietic progenitor cell identification in fetal and adult bloodMüller,AixaSoyano,AndrésGuevara,FreddyMartínez,BahildaSoyano,AlbertoPonte,Benita Hemopoietic progenitor cell flow cytometry CD34+ cells apheresis mobilization cord blood Hemopoietic progenitor cells give rise to all cellular elements of the blood and are of importance as a potential source of cells used for correction of various pathological conditions. The main objective of this study was to identify and quantitative hemopoietic progenitor cell in antenatal fetal blood, in cord blood at the time of delivery and in adult blood, using monoclonal antibodies to surface markers and flow cytometry. CD34+ cells, most of them probably representing progenitor cells, were detected in prenatal fetal blood as early as the 17th week of gestation. The proportion of these cells showed a tendency to decrease as the pregnancy progressed. Within the population of CD34+ cells, a relatively low proportion (less than 1%) were negative for the surface marker CD33 or HLA-Dr, indicating a population of primitive stem cells, i.e., progenitor cells no committed to a specific lineage. On the contrary, another group coexpressed CD33 or HLA-Dr, being more mature progenitor cells already committed to differentiate along a specific lineage. The percentage of CD34+ obtained in blood of adult patients after mobilization with chemotherapeutic agents and growth factors showed an average value of 2.7± 3.1%. The percentage of CD34+ in the apheresis products of various patients varied from 0.58 to 1.48. In some cases the cells were reinfused in the patient with good results. Our findings are in agreement with previous studies suggesting that CD34+ stem cells is a heterogeneous population, with each subset having variable degree o commitment to differentiate toward a specific cell lineage.info:eu-repo/semantics/openAccessAssociação Brasileira de Hematologia e Hemoterapia e Terapia CelularRevista Brasileira de Hematologia e Hemoterapia v.30 suppl.2 20082008-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800006en
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Müller,Aixa
Soyano,Andrés
Guevara,Freddy
Martínez,Bahilda
Soyano,Alberto
Ponte,Benita
spellingShingle Müller,Aixa
Soyano,Andrés
Guevara,Freddy
Martínez,Bahilda
Soyano,Alberto
Ponte,Benita
Hemopoietic progenitor cell identification in fetal and adult blood
author_facet Müller,Aixa
Soyano,Andrés
Guevara,Freddy
Martínez,Bahilda
Soyano,Alberto
Ponte,Benita
author_sort Müller,Aixa
title Hemopoietic progenitor cell identification in fetal and adult blood
title_short Hemopoietic progenitor cell identification in fetal and adult blood
title_full Hemopoietic progenitor cell identification in fetal and adult blood
title_fullStr Hemopoietic progenitor cell identification in fetal and adult blood
title_full_unstemmed Hemopoietic progenitor cell identification in fetal and adult blood
title_sort hemopoietic progenitor cell identification in fetal and adult blood
description Hemopoietic progenitor cells give rise to all cellular elements of the blood and are of importance as a potential source of cells used for correction of various pathological conditions. The main objective of this study was to identify and quantitative hemopoietic progenitor cell in antenatal fetal blood, in cord blood at the time of delivery and in adult blood, using monoclonal antibodies to surface markers and flow cytometry. CD34+ cells, most of them probably representing progenitor cells, were detected in prenatal fetal blood as early as the 17th week of gestation. The proportion of these cells showed a tendency to decrease as the pregnancy progressed. Within the population of CD34+ cells, a relatively low proportion (less than 1%) were negative for the surface marker CD33 or HLA-Dr, indicating a population of primitive stem cells, i.e., progenitor cells no committed to a specific lineage. On the contrary, another group coexpressed CD33 or HLA-Dr, being more mature progenitor cells already committed to differentiate along a specific lineage. The percentage of CD34+ obtained in blood of adult patients after mobilization with chemotherapeutic agents and growth factors showed an average value of 2.7± 3.1%. The percentage of CD34+ in the apheresis products of various patients varied from 0.58 to 1.48. In some cases the cells were reinfused in the patient with good results. Our findings are in agreement with previous studies suggesting that CD34+ stem cells is a heterogeneous population, with each subset having variable degree o commitment to differentiate toward a specific cell lineage.
publisher Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular
publishDate 2008
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800006
work_keys_str_mv AT mulleraixa hemopoieticprogenitorcellidentificationinfetalandadultblood
AT soyanoandres hemopoieticprogenitorcellidentificationinfetalandadultblood
AT guevarafreddy hemopoieticprogenitorcellidentificationinfetalandadultblood
AT martinezbahilda hemopoieticprogenitorcellidentificationinfetalandadultblood
AT soyanoalberto hemopoieticprogenitorcellidentificationinfetalandadultblood
AT pontebenita hemopoieticprogenitorcellidentificationinfetalandadultblood
_version_ 1756423450688225280